Is compounded tirzepatide safe?
There is no honest yes that skips the FDA frame. Compounded drugs do not undergo premarket review for safety, effectiveness, or quality. PinwellRx will not invent a safety percentage.
Read What is compounded tirzepatide? and What is a compounding pharmacy? first. The FDA's compounding guidance is the honest frame: compounding serves patients whose needs are not met by manufactured options, and quality rests on the licensed pharmacy that prepares each dose. GLP-1 class medications commonly cause nausea and digestive side effects, and are not appropriate for everyone. Certain histories, including some thyroid conditions, rule them out. That is the screen the clinician performs, and why they can decline.
Why is compounded tirzepatide not FDA-approved?
Because it is compounded under section 503A, not manufactured as an approved new drug. The FDA states that compounded drugs are not FDA-approved.
The FDA has also published concerns about unapproved GLP-1 drugs used for weight loss, including compounded versions. Read that page. PinwellRx does not outrank the FDA on this point.
Who should not take a GLP-1?
That is a clinical decision. A licensed clinician reviews your history, medications, and goals. They can say no. Full refund if you are not prescribed.
This page is not a screening tool. If you want a decision, start a consult. Compounded tirzepatide injection is listed at $339 per 4 weeks.